Search

Search Constraints

You searched for: Author/Creator Rey, Philippe

Search Results

1. Apixaban for the prevention of thromboembolism in immunomodulatory‐treated myeloma patients: Myelaxat, a phase 2 pilot study. Issue 6 (1st April 2019)

2. High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR. (August 2020)

3. Impact of the introduction of rituximab in first‐line follicular lymphoma: a retrospective study of 247 unselected patients referred to a single institution with a long‐term follow‐up. Issue 1 (5th February 2014)

4. Individualised physical activity programme in patients over 65 years with haematological malignancies (OCAPI): protocol for a single-arm feasibility trial. Issue 6 (3rd June 2021)

5. Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study. Issue 2 (February 2022)

6. Rituximab in combination with adapted-dose of ifosfamide and etoposide as salvage treatment in elderly refractory/relapsed diffuse large B-cell lymphoma patients non-candidate for high dose therapy: a retrospective study. Issue 3 (23rd February 2022)

7. Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse. (February 2017)